Code | 8541D | ||||||||||
MA number | EU/1/21/1575/006 | ||||||||||
Product Form: | sol inj 2x1 ml/160 mg (pero napl.) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
MAH, country: | UCB Pharma S.A. , Belgium | ||||||||||
Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Route of admin.: | Subcutaneous use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 8(3) application - new active substance |
MA issued: | 20.08.2021 |
Validity: | 20.08.2026 |
SmPC + PL: | European Medicines Agency's database |
Safety feature | Yes |
Data update: | 09.09.2021 |